We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Data on the real-world efficacy of the COVID-19 vaccines.
Ref: PHE publications gateway number: GOV-8775
PDF, 910 KB, 6 pages
This file may not be suitable for users of assistive technology.
Ref: PHE publications gateway number: GOV-7989
PDF, 624 KB, 8 pages
This file may not be suitable for users of assistive technology.
Ref: PHE gateway number GOV-7803
PDF, 576 KB, 11 pages
This file may not be suitable for users of assistive technology.
Ref: PHE publications gateway number: GOV-7777
PDF, 625 KB, 11 pages
This file may not be suitable for users of assistive technology.
Ref: PHE publications gateway number: GW-1970
PDF, 1.15 MB, 17 pages
This file may not be suitable for users of assistive technology.
On 8 December 2020, the UK became the first country to roll out a coronavirus (COVID-19) vaccination programme, initially using the Pfizer/BioNTech vaccine.
Since the beginning of the programme, Public Health England (PHE) has been monitoring the effectiveness of the vaccines in the real world as set out in the COVID-19 vaccine surveillance strategy and has now published its first analysis of the impact of the Pfizer/BioNTech vaccine on:
For the latest reports please see the UK Health Security Agency monitoring reports of the effectiveness of COVID-19 vaccination.
Weekly COVID-19 vaccine surveillance reports are available.
Added link to ‘vaccine effectiveness and duration of protection study’.
Added link to Different dosing schedules and vaccine effectiveness study.
Added link to vaccine effectiveness in clinical risk groups report.
Added ‘Direct and indirect impact of the vaccination programme on COVID-19 infections and mortality’ report.
Added link to ‘Vaccine effectiveness with Delta variant’.
Updated PHE monitoring of the early impact and effectiveness of COVID-19 vaccination in England, March 2021 – title of figure 1 corrected.
Added link ‘Vaccine effectiveness with B.1.617.2 variant’.
Added link to weekly surveillance report.
Added link to the effectiveness of COVID-19 vaccines on mortality study, effectiveness of COVID-19 vaccines against hospitalisation study and summary of evidence on vaccine effectiveness against different outcomes.
Added link to ‘Impact of vaccination on household transmission of SARS-COV-2 in England’.
Added links to the VIVALDI and Avon CAP studies.
Added December 2020 to March 2021 report.
Added link to Early effectiveness of COVID-19 vaccines in older adults.
Added Impact of COVID-19 vaccines on mortality in England: December 2020 to February 2021.
Added latest version of report and link to seroprevalence document.
Added link to the SIREN study.
First published.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.

source

Optimized by Optimole